NCBP1
Nuclear cap-binding protein subunit 1
Also known as: CBP80, NCBP, NCBP1_HUMAN, Sto1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q09161
- Gene
- NCBP1
- Ensembl
- ENSG00000136937
- Chromosome
- 9
- Canonical length
- 790 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The product of this gene is a component of the nuclear cap-binding protein complex (CBC), which binds to the monomethylated 5' cap of nascent pre-mRNA in the nucleoplasm. The encoded protein promotes high-affinity mRNA-cap binding and associates with the CTD of RNA polymerase II. The CBC promotes pre-mRNA splicing, 3'-end processing, RNA nuclear export, and nonsense-mediated mRNA decay. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
790 residues, UniProt reviewed canonical sequence.
>Q09161|NCBP1
1 MSRRRHSDEN DGGQPHKRRK TSDANETEDH LESLICKVGE KSACSLESNL EGLAGVLEAD
61 LPNYKSKILR LLCTVARLLP EKLTIYTTLV GLLNARNYNF GGEFVEAMIR QLKESLKANN
121 YNEAVYLVRF LSDLVNCHVI AAPSMVAMFE NFVSVTQEED VPQVRRDWYV YAFLSSLPWV
181 GKELYEKKDA EMDRIFANTE SYLKRRQKTH VPMLQVWTAD KPHPQEEYLD CLWAQIQKLK
241 KDRWQERHIL RPYLAFDSIL CEALQHNLPP FTPPPHTEDS VYPMPRVIFR MFDYTDDPEG
301 PVMPGSHSVE RFVIEENLHC IIKSHWKERK TCAAQLVSYP GKNKIPLNYH IVEVIFAELF
361 QLPAPPHIDV MYTTLLIELC KLQPGSLPQV LAQATEMLYM RLDTMNTTCV DRFINWFSHH
421 LSNFQFRWSW EDWSDCLSQD PESPKPKFVR EVLEKCMRLS YHQRILDIVP PTFSALCPAN
481 PTCIYKYGDE SSNSLPGHSV ALCLAVAFKS KATNDEIFSI LKDVPNPNQD DDDDEGFSFN
541 PLKIEVFVQT LLHLAAKSFS HSFSALAKFH EVFKTLAESD EGKLHVLRVM FEVWRNHPQM
601 IAVLVDKMIR TQIVDCAAVA NWIFSSELSR DFTRLFVWEI LHSTIRKMNK HVLKIQKELE
661 EAKEKLARQH KRRSDDDDRS SDRKDGVLEE QIERLQEKVE SAQSEQKNLF LVIFQRFIMI
721 LTEHLVRCET DGTSVLTPWY KNCIERLQQI FLQHHQIIQQ YMVTLENLLF TAELDPHILA
781 VFQQFCALQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- retina: 28 nTPM
- bone marrow: 28 nTPM
- thymus: 20 nTPM
- lymph node: 18 nTPM
- skeletal muscle: 18 nTPM
- tonsil: 17 nTPM
Single-cell type
- cardiomyocytes: 203 nCPM
- epicardial cells: 177 nCPM
- myonuclei: 103 nCPM
- adipocytes: 66 nCPM
- monocyte progenitors: 61 nCPM
- neutrophil progenitors: 58 nCPM
Immune cell
- basophil: 14 nTPM
- non-classical monocyte: 14 nTPM
- intermediate monocyte: 13 nTPM
- myeloid DC: 13 nTPM
- NK-cell: 13 nTPM
- classical monocyte: 10 nTPM
Brain region
- cerebellum: 74 nTPM
- white matter: 49 nTPM
- basal ganglia: 43 nTPM
- cerebral cortex: 43 nTPM
- hippocampal formation: 40 nTPM
- medulla oblongata: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.09
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.52
- DepMap mean gene effect
- -1.42
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 7-methylguanosine mRNA capping
- alternative mRNA splicing, via spliceosome
- cap-dependent translational initiation
- defense response to virus
- histone mRNA metabolic process
- miRNA-mediated post-transcriptional gene silencing
- mRNA 3'-end processing
- mRNA export from nucleus
- mRNA metabolic process
- mRNA splicing, via spliceosome
- mRNA transcription by RNA polymerase II
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- positive regulation of cell growth
- positive regulation of mRNA 3'-end processing
- positive regulation of mRNA splicing, via spliceosome
- positive regulation of transcription elongation by RNA polymerase II
- primary miRNA processing
- regulation of mRNA processing
- regulation of translational initiation
- regulatory ncRNA-mediated post-transcriptional gene silencing
- RNA catabolic process
- RNA splicing
- snRNA export from nucleus
- spliceosomal complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MIF4G-like, type 3
- Armadillo-type fold
- MIF4G domain
- MIF4G-like, type 1
- MIF4G-like, type 2
- Nuclear cap-binding protein subunit 1
- MIF4G like
- MIF4G like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCBP1 as an antibody target. Whether an autoantibody or antibody against NCBP1 could matter depends on whether native NCBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCBP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...